Oral Hormone Replacement Therapy

An individualised approach should be taken with each person needing support with the menopause, refer to Menopause and Hormone Replacement Therapy page for diagnosis and management of people with symptoms of menopause.

Oral HRT is more cost effective but treatment options need to be individualised based on patient risk factors and preference. Transdermal route may be more appropriate for patients with risk factors as detailed in NICE.

The risk of VTE associated with HRT is greater for oral than transdermal preparations.

See [NG23] Menopause: diagnosis and management recommendation 1.5 for more information on long term benefits and risks of hormone replacement therapy.